Therapeutic Solutions International, Inc. (TSOI)
USD 0.0
(50.0%)
USD 0.0
(50.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 98.99 Thousand | 206.76 Thousand | 145.95 Thousand | 62.68 Thousand | 27.49 Thousand | 3484.00 |
| Cost of Revenue | 36.76 Thousand | 79.44 Thousand | 42.54 Thousand | 12.79 Thousand | 3015.00 | 2157.00 |
| Gross Profit | 62.22 Thousand | 127.32 Thousand | 103.41 Thousand | 49.88 Thousand | 24.48 Thousand | 1327.00 |
| Operating Expenses | 2.04 Million | 3.2 Million | 2.4 Million | 1.89 Million | 1.06 Million | 1.2 Million |
| Selling, General and Administrative Expenses | 1.48 Million | 1.76 Million | 1.61 Million | 1.33 Million | 1.03 Million | 1.12 Million |
| Research and Development Expenses | 560.65 Thousand | 1.44 Million | 794.75 Thousand | 561.99 Thousand | 27.68 Thousand | 74.97 Thousand |
| Other Expenses | - | -110.64 Thousand | 658.55 Thousand | -6721.00 | 838.49 Thousand | 525.79 Thousand |
| Cost and Expenses | 2.08 Million | 3.28 Million | 2.45 Million | 1.91 Million | 1.07 Million | 1.2 Million |
| Operating Income | -1.98 Million | -3.07 Million | -2.3 Million | -1.84 Million | -1.04 Million | -1.19 Million |
| Interest Expense | 423.26 Thousand | 646.08 Thousand | 611.79 Thousand | 302.48 Thousand | 350.74 Thousand | 241.75 Thousand |
| Income Tax Expense | 2250.00 | 800.00 | 800.00 | 295.76 Thousand | 350.74 Thousand | 667.1 Thousand |
| Earnings before Tax | -2.22 Million | -3.67 Million | -2.96 Million | -2.19 Million | -1.69 Million | -1.86 Million |
| Net Income | -2.16 Million | -3.67 Million | -2.96 Million | -2.49 Million | -2.04 Million | -1.86 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 3.16 Billion | 2.52 Billion | 2.26 Billion | 1.91 Billion | 1.28 Billion | 896.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.16 Billion | 2.52 Billion | 2.26 Billion | 1.91 Billion | 1.28 Billion | 896.85 Million |
| Gross Margin | 0.63 | 0.62 | 0.71 | 0.80 | 0.89 | 0.38 |
| EBIT Margin | -15.03 | -14.25 | -15.66 | -29.50 | -37.70 | -344.38 |
| Profit Margin | -21.92 | -17.79 | -20.29 | -39.82 | -74.49 | -535.85 |
| EBITDA | -1.48 Million | -2.98 Million | -2.33 Million | -1.89 Million | -1.33 Million | -1.19 Million |
| Earnings Before Tax Margin | -20.07 | -14.90 | -15.79 | -29.51 | -37.94 | -344.38 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 20 Thousand | 21.81 Million | 98.99 Thousand | 23.83 Thousand | 25.73 Million | 26.3 Thousand |
| Cost of Revenue | 187.81 Thousand | 7.49 Million | 781.87 Thousand | 189.21 Thousand | 7.05 Million | 10.69 Thousand |
| Gross Profit | -167.81 Thousand | 14.32 Million | -682.87 Thousand | -165.37 Thousand | 18.67 Million | 15.6 Thousand |
| Operating Expenses | 236.22 Thousand | 680.07 Million | 1.3 Million | 391.39 Thousand | 468.96 Million | 558.11 Thousand |
| Selling, General and Administrative Expenses | 218.65 Thousand | 258.45 Million | - | 240.88 Thousand | 195.76 Million | 349.57 Thousand |
| Research and Development Expenses | 17.57 Thousand | 58.61 Million | - | 150.5 Thousand | 148.87 Million | 208.54 Thousand |
| Other Expenses | 104.77 Million | 363 Million | 545.12 Million | 420.8 Million | 124.31 Million | 156.72 Million |
| Cost and Expenses | 424.04 Thousand | 687.56 Million | 2.08 Million | 580.6 Thousand | 476.01 Million | 568.81 Thousand |
| Operating Income | -404.04 Thousand | -673.24 Million | -1.98 Million | -556.77 Thousand | -457.33 Million | -542.5 Thousand |
| Interest Expense | 74.01 Thousand | -89.19 Million | 423.26 Thousand | 96.13 Thousand | -83.06 Million | 122.26 Thousand |
| Income Tax Expense | 800.00 | -179.12 Million | 2250.00 | 1450.00 | -816 Thousand | 800.00 |
| Earnings before Tax | -463.55 Thousand | -764.26 Million | -2.22 Million | -479.25 Thousand | -602.85 Million | -562.45 Thousand |
| Net Income | -390.04 Thousand | -585.14 Million | -2.16 Million | -427.49 Thousand | -602.04 Million | -562.4 Thousand |
| Earnings Per Share Basic | -0.00 | -0.15 | - | -0.00 | -0.18 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.15 | - | -0.00 | -0.18 | -0.00 |
| Weighted Average Shares Outstanding | 4.51 Billion | 3.95 Billion | 3.16 Billion | 3.8 Billion | 3.28 Billion | 2.97 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.51 Billion | 3.95 Billion | 3.16 Billion | 3.8 Billion | 3.28 Billion | 2.97 Billion |
| Gross Margin | -8.39 | 0.66 | -6.90 | -6.94 | 0.73 | 0.59 |
| EBIT Margin | -16.35 | -30.86 | - | -19.96 | -17.77 | -17.70 |
| Profit Margin | -19.50 | -26.82 | -21.92 | -17.94 | -23.40 | -21.38 |
| EBITDA | -327.13 Thousand | -673.24 Million | - | -475.73 Thousand | -457.33 Million | -465.59 Thousand |
| Earnings Before Tax Margin | -20.20 | -30.86 | -20.07 | -23.36 | -17.77 | -20.62 |
TRINL
0R30
MIHL
CDM1
TITLE
GSJ